CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that its collaboration with Roche received the award for ‘Best Partnership Alliance’ at the fourth annual 2008 Scrip Awards, held in London last night. The Scrip Awards, awarded by Scrip World Pharmaceutical News, recognize excellence and achievement in the global pharmaceutical and biotechnology industries.
